These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11712815)

  • 1. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
    Trulson I; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
    Trulson I; Klawonn F; von Pawel J; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.
    Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis.
    Nasralla A; Lee J; Dang J; Turner S
    J Cardiothorac Surg; 2020 Oct; 15(1):318. PubMed ID: 33059696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
    Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
    Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study on the reference intervals of serum tumor marker in apparently healthy elderly population in southwestern China using real-world data.
    Miao Q; Lei S; Chen F; Niu Q; Luo H; Cai B
    BMC Cancer; 2024 May; 24(1):657. PubMed ID: 38811867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves.
    Dou X; Lu J; Yu Y; Yi Y; Zhou L
    Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-analytical stability of the CEA, CYFRA 21.1, NSE, CA125 and HE4 tumor markers.
    Canki E; Schuurbiers MM; Linders TC; Korse CM; van den Heuvel MM; van Herwaarden AE; van Rossum HH
    Tumour Biol; 2024; 46(s1):S15-S25. PubMed ID: 37302060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized uptake value
    Jin B; Wen X; Tian H; Guo H; Hao M; Wu J; Li X; Ren Y; Wang X; Ren X
    Cancer Med; 2024 Apr; 13(7):e6961. PubMed ID: 38549459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management.
    Strum S; Vincent M; Gipson M; McArthur E; Breadner D
    Oncotarget; 2024 Jun; 15():381-388. PubMed ID: 38870072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma.
    Chen Z; Wang Y; Fang M
    Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating lung cancer biomarkers: From translational research to clinical practice.
    Qian X; Meng QH
    Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
    Izawa A; Hara Y; Horita N; Muraoka S; Kaneko M; Kaneko A; Somekawa K; Hirata M; Otsu Y; Matsumoto H; Nagasawa R; Tanaka K; Kubo S; Murohashi K; Aoki A; Fujii H; Watanabe K; Kobayashi N; Miura K; Nakajima H; Kaneko T
    Transl Lung Cancer Res; 2024 Mar; 13(3):503-511. PubMed ID: 38601457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies.
    van den Heuvel M; Holdenrieder S; Schuurbiers M; Cigoianu D; Trulson I; van Rossum H; Lang D
    Tumour Biol; 2024; 46(s1):S233-S268. PubMed ID: 37248927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing modeling strategies combining changes in multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
    van Delft FA; Schuurbiers MMF; Muller M; Burgers SA; van Rossum HH; IJzerman MJ; van den Heuvel MM; Koffijberg H
    Tumour Biol; 2024; 46(s1):S269-S281. PubMed ID: 37545289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of goldilocks: the quest to optimize combination drug strategies for the management of advanced stage non-small-cell lung cancer.
    Bindal P; Widick P; Costa DB; Rangachari D
    Transl Cancer Res; 2020 Mar; 9(3):1311-1318. PubMed ID: 35117478
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE.
    Molina R; Auge JM; Escudero JM; Marrades R; Viñolas N; Carcereny E; Ramirez J; Filella X
    Tumour Biol; 2008; 29(6):371-80. PubMed ID: 19060513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five tumor-associated autoantibodies expression levels in serum predict lung cancer and associate with poor outcome.
    Li S; Ma Y; Xiong Y; Zhang P; Wang X; Wang Y; Yang Y
    Transl Cancer Res; 2019 Aug; 8(4):1364-1373. PubMed ID: 35116879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.